-
1 Comment
Zhuhai Rundu Pharmaceutical Co., Ltd is currently in a long term uptrend where the price is trading 27.8% above its 200 day moving average.
From a valuation standpoint, the stock is 75.1% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 2.4.
Zhuhai Rundu Pharmaceutical Co., Ltd's total revenue sank by 11.1% to $303M since the same quarter in the previous year.
Its net income has increased by 69.8% to $34M since the same quarter in the previous year.
Finally, its free cash flow grew by 297.0% to $86M since the same quarter in the previous year.
Based on the above factors, Zhuhai Rundu Pharmaceutical Co., Ltd gets an overall score of 4/5.
| Industry | Drug Manufacturers - Specialty & Generic |
|---|---|
| Sector | Healthcare |
| Exchange | SHE |
| CurrencyCode | CNY |
| ISIN | CNE1000033G8 |
| PE Ratio | 112.0 |
|---|---|
| Target Price | None |
| Dividend Yield | 1.5% |
| Beta | 0.32 |
| Market Cap | 4B |
Zhuhai Rundu Pharmaceutical Co., Ltd. develops, produces, and markets pharmaceutical ingredients for cardiovascular, gastrointestinal, and CNS worldwide. It offers APIs, intermediates, FDF, and pellets. The company was founded in 1997 and is headquartered in Zhuhai, China.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 002923.SHE using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
